Interactions Between Anticonvulsant and Psychoactive Drugs

This review considers the relevance of pharmaco‐kinetic interactions between antiepileptic drugs (AEDs) and psychoactive drugs in the treatment of mood disorders in patients with epilepsy. The determination of plasma levels of some of these drugs (mainly the AEDs) has enabled clinicians to evaluate the kinetic modifications during the course of such combined therapies and to adjusting the dosages in cases of subtherapeutic or toxic levels. In general, phenobarbital, phenytoin, and carbamazepine stimulate the catabolic degradation of tricyclic antidepressants (TCAs), and TCAs have an inhibitory effect on the elimination of AEDs. The newer antidepressants that selectively inhibit the reuptake of serotonin (SSRIs), although in different fashions for the different substances (fluoxetine, fluvoxamine, paroxetine) may cause an increase of plasma AED levels through inhibition of the isoenzyme P450 2D6. Similarly, antipsychotics (APs) are more rapidly metabolized when AEDs are co‐administered, whereas AED metabolism is scarcely influenced by AP. Finally, plasma levels of tranquilizers are lowered by AED co‐therapy. As the concomitant administration of AED and psychoactive drugs becomes increasingly used for treatment of mood disorders in patients with or without epilepsy, therapeutic drug monitoring may be useful in designing correct and rational therapy.

[1]  A. Richens,et al.  Effect of Drug Therapy on the Metabolism of Phenytoin , 1975 .

[2]  B. Wroblewski,et al.  Potentially toxic serum concentrations of desipramine after discontinuation of valproic acid. , 1993, Brain injury.

[3]  R. Wyatt,et al.  Seizures with Antidepressants: An In Vitro Technique to Assess Relative Risk , 1984, Epilepsia.

[4]  A. Richens,et al.  Valproic acid and diazepam interaction in vivo. , 1982, British journal of clinical pharmacology.

[5]  M. Linnoila,et al.  Effect of anticonvulsants on plasma haloperidol and thioridazine levels. , 1980, The American journal of psychiatry.

[6]  J. D. Robinson,et al.  Effect of Thioridazine on Phenytoin Serum Concentration: A Retrospective Study , 1987, Drug intelligence & clinical pharmacy.

[7]  M. Huttunen,et al.  Carbamazepine and plasma levels of clozapine. , 1993, The American journal of psychiatry.

[8]  A. Richens,et al.  Bioavailability of diazepam after intravenous, oral and rectal administration in adult epileptic patients. , 1982, British journal of clinical pharmacology.

[9]  S. Shukla,et al.  Lithium-carbamazepine neurotoxicity and risk factors. , 1984, The American journal of psychiatry.

[10]  E. Perucca.  Pharmacokinetic Interactions with Antiepileptic Drugs , 1982, Clinical pharmacokinetics.

[11]  R. Dreyer.  Die Pharmakotherapie der Epilepsien , 1972 .

[12]  T. Browne.  Clinical pharmacology of antiepileptic drugs. , 1978, The Journal of the Maine Medical Association.

[13]  M. Micheletti,et al.  The psychoses of epilepsy , 2001, Journal of neurology, neurosurgery, and psychiatry.

[14]  D. Greenblatt,et al.  Carbamazepine-induced reduction of plasma alprazolam concentrations: a clinical case report. , 1988, The Journal of clinical psychiatry.

[15]  D. Coulter,et al.  Interaction of phenytoin and fluoxetine. , 1994, The New Zealand medical journal.

[16]  E. Perucca,et al.  Effect of Fluvoxamine on the Pharmacokinetics of Imipramine and Desipramine in Healthy Subjects , 1993, Therapeutic drug monitoring.

[17]  I. Watson,et al.  Induction of imipramine metabolism following barbiturate administration [proceedings]. , 1977, British journal of clinical pharmacology.

[18]  E. Perucca,et al.  Clinically Significant Pharmacokinetic Drug Interactions with Carbamazepine , 1996, Clinical pharmacokinetics.

[19]  M. Trimble,et al.  Clinical Use of Anticonvulsants in Psychiatric Disorders , 1989 .

[20]  K. Gale,et al.  Anticonvulsant Effect of Fluoxetine on Focally Evoked Limbic Motor Seizures in Rats , 1993, Epilepsia.

[21]  T. Suppes,et al.  A clinically significant interaction between clozapine and valproate. , 1995, Journal of clinical psychopharmacology.

[22]  C. DeVane.  Pharmacogenetics and drug metabolism of newer antidepressant agents. , 1994, The Journal of clinical psychiatry.

[23]  M. Marciani,et al.  Lack of potentiation of anticonvulsant effect by fluoxetine in drug-resistant epilepsy , 1994, Seizure.

[24]  C. Bowden,et al.  Effects of carbamazepine on plasma haloperidol levels. , 1985, Journal of clinical psychopharmacology.

[25]  D. Miller.  Effect of phenytoin on plasma clozapine concentrations in two patients. , 1991, The Journal of clinical psychiatry.

[26]  S. Dursun,et al.  Toxic serotonin syndrome after fluoxetine plus carbamazepine , 1993, The Lancet.

[27]  D. Goff,et al.  Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms? , 1986, The American journal of psychiatry.

[28]  B. Pollock,et al.  Newer antidepressants and the cytochrome P450 system. , 1996, The American journal of psychiatry.

[29]  The drug-drug interaction effects of haloperidol on plasma carbamazepine levels. , 1995, Clinical neuropharmacology.

[30]  C. Salzman,et al.  Valproic acid effects on serum concentrations of clozapine and norclozapine. , 1995, The American journal of psychiatry.

[31]  E. Perucca,et al.  PHARMACOKINETIC INTERACTIONS BETWEEN ANTIEPILEPTIC AND PSYCHOTROPIC DRUGS , 1984 .

[32]  J. A. Madsen,et al.  Interaction between phenobarbital and thioridazine , 1983, Neurology.

[33]  M. Dam,et al.  No influence of the antidepressant paroxetine on carbamazepine, valproate and phenytoin , 1991, Epilepsy Research.

[34]  H. Kutt.  Interactions Between Anticonvulsants and Other Commonly Prescribed Drugs , 1984, Epilepsia.

[35]  A. Richens,et al.  Serum protein binding of diazepam and its displacement by valproic acid in vitro. , 1981, British journal of clinical pharmacology.

[36]  Devane Cl.  Pharmacogenetics and Drug Metabolism of Newer Antidepressant Agents , 1994 .

[37]  T. Tomson,et al.  Single‐Dose Kinetics of an Enteric‐Coated Formulation of Carbamazepine‐10,11‐epoxide, an Active Metabolite of Carbamazepine , 1988, Therapeutic drug monitoring.

[38]  D. Goff,et al.  Clinically Significant Interactions of Psychotropic Agents with Antipsychotic Drugs , 1996, Drug safety.

[39]  B. Pollock,et al.  Dr. Nemeroff and Colleagues Reply , 1996 .

[40]  M. Åsberg,et al.  Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depression , 1979, Clinical pharmacology and therapeutics.

[41]  P. Turner,et al.  INTERACTIONS OF ANTICONVULSANT DRUGS WITH MIANSERIN AND NOMIFENSINE , 1981, The Lancet.

[42]  V. Laulumaa,et al.  CARBAMAZEPINE IN TREATMENT OF VIOLENT SCHIZOPHRENICS , 1982, The Lancet.

[43]  M. Del Zompo,et al.  An interaction between carbamazepine and fluvoxamine. , 1993, British journal of clinical pharmacology.

[44]  A. Avenoso,et al.  Carbamazepine coadministration with fluoxetine or fluvoxamine. , 1993, Therapeutic drug monitoring.

[45]  D. Touw,et al.  Fluoxetine and parkinsonism in patients taking carbamazepine. , 1991, The American journal of psychiatry.

[46]  J. Darley.  Interaction between phenytoin and fluoxetine , 1994, Seizure.

[47]  N. S. Harvey,et al.  Compliance, the LAQ, and a new laboratory method of measuring RBC lithium. , 1990, The Journal of clinical psychiatry.

[48]  R. Post,et al.  The Efficacy and Use of Anticonvulsants in Mood Disorders , 1998, Clinical neuropharmacology.

[49]  R. Braithwaite,et al.  Steady-state plasma nortriptyline concentrations in epileptic patients. , 1975, British journal of clinical pharmacology.

[50]  S. Preskorn,et al.  Therapeutic drug monitoring for antidepressants: efficacy, safety, and cost effectiveness. , 1991, The Journal of clinical psychiatry.

[51]  R. Baldessarini,et al.  Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate. , 1994, The American journal of psychiatry.

[52]  E. Perucca,et al.  Elevation of plasma phenytoin by viloxazine in epileptic patients: a clinically significant drug interaction. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[53]  M. Jann,et al.  Increased carbamazepine plasma concentrations after fluoxetine coadministration , 1991, Clinical pharmacology and therapeutics.

[54]  E. Perucca,et al.  Interaction between phenytoin and imipramine. , 1977, British journal of clinical pharmacology.

[55]  Gray Jg,et al.  LIVING AND DYING IN THE NINETEENTH CENTURY. , 1963 .

[56]  L. Ereshefsky,et al.  Serotonin selective reuptake inhibitor drug interactions and the cytochrome P450 system. , 1996, The Journal of clinical psychiatry.

[57]  E. Favale,et al.  Anticonvulsant effect of fluoxetine in humans , 1995, Neurology.

[58]  E. Perucca,et al.  Carbamazepine-viloxazine interaction in patients with epilepsy. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[59]  P. Jalil.  Toxic reaction following the combined administration of fluoxetine and phenytoin: two case reports. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[60]  Leander Jd.  Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine, and ameltolide (LY201116). , 1992 .

[61]  D. Chadwick.  The Psychopharmacology of Epilepsy , 1985 .

[62]  F. Vincent.  Phenothiazine-induced phenytoin intoxication. , 1980, Annals of internal medicine.

[63]  Gidal Be,et al.  Evaluation of the effect of fluoxetine on the formation of carbamazepine epoxide. , 1993 .

[64]  P. Janicak.  The relevance of clinical pharmacokinetics and therapeutic drug monitoring: anticonvulsant mood stabilizers and antipsychotics. , 1993, The Journal of clinical psychiatry.

[65]  G. Keepers.  Neuroleptic malignant syndrome associated with withdrawal from carbamazepine. , 1990, The American journal of psychiatry.

[66]  G. Bertschy,et al.  Valpromide Increases the Plasma Concentrations of Amitriptyline and Its Metabolite Nortriptyline in Depressive Patients , 1988, Therapeutic drug monitoring.

[67]  D. Bergen.  Antiepileptic Drugs, 4th Ed , 1996, Neurology.

[68]  H. J. Pearson.  Interaction of fluoxetine with carbamazepine. , 1990, The Journal of clinical psychiatry.